Brief: Idera Pharmaceuticals Inc Reports Qtrly Loss Per Share Of $0.40
May 2 (Reuters) - Idera Pharmaceuticals Inc IDRA.O :
* IDERA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE OF $0.40
PER
BASIC AND DILUTED SHARE
* IDERA PHARMACEUTICALS - AS OF MARCH 31, 2019, CASH, CASH
EQUIVALENTS AND INVESTMENTS TOTALED $59.9 MILLION COMPARED TO
$71.4 MILLION AS OF DECEMBER 31, 2018
Source : (https://bit.ly/2PFp8vx)
Further company coverage: IDRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aceragen
See all newsBrief: Aceragen CEO John Taylor's Employment With Co Terminated
Brief: Aceragen Inc To Delist From The Nasdaq Stock Market
Aceragen Inc expected to post a loss of $1.20 a share - Earnings Preview
Brief: Aceragen Board Determined It Is In Best Interests Of Co,To Effect Transfer,Assignment Of All Of Co's Assets To Assignee
Aceragen Inc reports results for the quarter ended in March - Earnings Summary